Showing posts with label open access. Show all posts
Showing posts with label open access. Show all posts

17 Sept 2010

Open access: the saviour for Chinese journals?

Discussing the announcement that the Chinese government is going to crack down on poor quality journals, a Nature editorial puts forward the welcome view that moving towards open access might be the best approach for Chinese publishers:

"The best opportunity to revive Chinese publishing, whether in Chinese or English, probably lies in an open-access platform — increasingly popular in Western journals. Many Chinese journals already charge authors a publication fee, so should be able to make a smooth transition to the open-access model, in which they are supported by fees rather than by subscription revenues."

5 Sept 2010

What is the scientific paper? 4: Access

This is a guest post by Joe Dunckley
Completing the series exploring the question "what is the scientific paper?", reposted from my old blog, and originally written following Science Online 2009. As I reminded people at the time, these were just my own half-thought through ideas, not the policy or manifesto of anyone or anything I'm affiliated with.
A friend of mine once told me how much she hated "the proliferation of these bioinformatics papers." All these simulations and models of what happens in real life. All of it utterly useless -- since when was the stuff that comes out of a computer worth anything? None of it even remotely reflects anything that happens in real life. And the methodology papers -- the endless methodology papers. They're making yet another neural network and modifying a bayesian something-or-other, when they haven't even found where they left the markov models yet! How can you have so many of these methodology papers? Clearly they can be no more than incremental advances. (Of course, BLAST is an exception -- it's old enough to have been around and heard of when we were undergrads, and is therefore a perfectly legitimate and mainstream molecular biology tool.)
Similarly, some people still voice their skepticism about the need for open access. Access isn't really a problem, is it? These open access advocates are just making facile arguments about the how the people who pay for scientific research should have some kind of say regarding its dissemination.[1] Come on, really, show me, who is in want of access? Everyone (everyone who matters) already has subscriptions, right? Access isn't a problem. And the open access "movement" isn't an ideology. It's just another business model.
And then, yesterday afternoon m'colleague shouted for advice handling an author of a scientific manuscript who was questioning the need to deposit her not inextensive collection of genomes in a database. I don't blame the author for wanting to get out of the chore—she had a lot of data, and depositing it will be a dull repetitive task. M'colleage was trying to write a letter and struggling to put into words the reason why we mandate deposition of sequence data, and why merely including them as supplementary MS Word files isn't good enough.
These attitudes, you will have noticed, have one particular thing in common: they all completely miss the fact that the biomedical sciences have moved on in the past quarter century. In almost every field (lets not wake the poor taxonomists) the science being done and the science being published today are not quite like that of 25 years ago. Even if the science of today were like that of 25 years ago the case for open data sharing would be strong enough; as it is, it's simply absurd to think that open sharing of data isn't worth doing.
--
Individual scientific papers -- the basic units of scientific research -- are rarely exciting; rarely even interesting. Where nerds get excited about science, it's where science offers a beautiful explanation for how the world works. And scientific papers don't do that. They offer some speculative interpretations of data on obscure problems in obscure systems. It is the literature as a whole -- hundreds of dull papers put together -- which tells a complete and exciting story. The sum is more than the parts -- the theory is more than the data.
In the field I know best -- cancer cell biology -- 99 in 100 papers published are tedious details, discovered with a science-by-numbers formula. The (anti-)proliferative effect of one abbreviation interacting with another abbreviation in three-letter-acronym-and-a-number cells, concluding with a suggestion that the authors' work might have implications for cancer treatment and a note that further work is necessary. Or even better, the complete lack of anything interesting at all happening when the first abbreviation interacts with the second. The abbreviations and their effects have been studied, in combination with others, in all of the most widely used three-letter-acronym-and-a-number cell-types, and somebody is scraping the barrel.
But the tedious details put together add up to an understanding of how the cell works and how it goes wrong. The details could be put together by a human, going through the thousands of papers on the topic, assembling the facts and finding the trends. Or, more plausibly, given the amount of tedious details out there, they could be assembled by a computer, with a database and a clever algorithm. Except that four in every five of those tedious details, discovered at great expense to taxpayers, will be inaccessible to that clever algorithm. They will be locked away in the basements of university libraries, hidden in human-readable prose that humans will never read. The results of billions of pounds of work searching for an understanding of cancer and a better chance at defeating it will be worthless, because they will never be amongst the parts that add up to the greater whole.
So I told m'colleague to explain to her author that unless she deposits her genome sequences, the last three years of her professional life will ultimately have been wasted. An average paper in a high-volume mid-tier journal that will be glanced at by a few colleagues when published. Another bullet point on a CV. They will never further science beyond that. They won't contribute any important discovery or real advance to the field. They will be forgotten. Nobody will seek them out when the time comes to make the leap forward.
That's just where biology is at these days: lots of tiny fragments of data, spread thin through the literature. The most interesting and important unanswered questions will require the synthesis of that work. The most interesting and important questions can't be answered without the heap of data that has already been produced, but which is locked away.
On machine readable data, Mike Ellis says, "at some point in the future, you'll want to do "something else" with your content. Right now you have no idea whatsoever what that something else might be." This is especially true in science: at some point in the future, tedious data obtained at great expensive, as part of the bigger picture, will finally be important and valuable. Right now, you can have no idea how important.
Publishers are allowed to get away with keeping science closed, holding it back, and wasting public money because there are still sufficient numbers of scientists who let them -- who have themselves failed to grasp that the world and science have changed.

31 Jul 2010

The stuff we didn't have time to blog about in July

This is a guest post by Joe Dunckley
Some old fashioned publishers are still claiming that open-access mandates -- by forcing the publishers to acknowledge that the internet has happened and that this event makes the status quo business model that they cling to wasteful and unsustainable -- will "stifle innovation". In other news, war has been found to be peace and it was discovered that freedom is slavery.

An unexpected and not entirely welcome development in open science: the Information Commissioner -- charged with enforcing the UK's freedom of information act -- has ruled that data collected by a Queen's University Belfast researcher falls under the remit of the act, and the data must now be released. This seems to be something of an accidental victory for open science, though rather unfortunate that it should come about as the result of a stunt by a climate change denier, and not as part of a planned, consensual, and multilateral shift in academic culture. I've yet to see much written on the repercussions of the decision (though I am a little behind on reading).

WikiReviews? A potentially interesting project for collaborating on "living" review articles, initially on cancer, introduced by George Lundberg.

Scientists who end up in industry could inadvertently find themselves in trouble when the natural tendency of the scientist to share information for the benefit of mankind conflicts with the natural tendency of big companies to jealously and zealously guard everything they have. In the US, researchers innocently publishing a scientific paper can face (at least, the threat of) decades in prison for industrial espionage if they're not very careful.

19 May 2010

"Predatory" open access publishers

The Charleston Adviser has published an interesting analysis of some of the recent open access 'upstarts', titled "“Predatory” Open-Access Scholarly Publishers". They include some that I've noted before such as Bentham Open and Scientific Journals International.

As I would have expected, Libertas Academica and its sister publisher Dove Press do better than the others included in this review, but they are still far from passing with flying colours. The reviewer, Jeffrey Beall of Auraria Library, University of Colorado Denver, places a very clear "author beware" sign on:

  • Academic Journals
  • Academic Journals
  • ANSINetswork
  • Bentham Open
  • Insight Knowledge
  • Knowledgia Review
  • Science Publications
  • Scientific Journals International
Beall's summary is worth repeating:
"These publishers are predatory because their mission is not to promote, preserve, and make available scholarship; instead, their mission is to exploit the author-pays, Open-Access model for their own profit.
They work by spamming scholarly e-mail lists, with calls for papers and invitations to serve on nominal editorial boards. If you subscribe to any professional e-mail lists, you likely have received some of these solicitations. Also, these publishers typically provide little or no peer-review. In fact, in most cases, their peer review process is a façade.
None of these publishers mentions digital preservation. Indeed, any of these publishers could disappear at a moment’s notice, resulting in the loss of its content."
I'd not touch any of them with a bargepole.

13 May 2010

Why you can't copy abstracts into Wikipedia

This is a guest post by Joe Dunckley
This is an archival repost of something first published elsewhere a year ago.

I am not a lawyer, but I do have six years experience of Wikipedia, was once a very prolific Wikipedian, and, despite my lack of activity there in more recent years, am apparently still an "admin" on the English language Wikipedia. This, coupled with working for an open-access publisher, means that I have also picked up a little knowledge of (mostly US & UK) copyright over the years. Since I can't boil all that down to just 250 characters (or whatever the limit is), this post serves to answer this question, raised at FriendFeed: 'Does an article in pubmed belong to the "legal public domain", can I copy and paste it in wikipedia?'

The answer is 'no'. I don't endorse this position, and I'm not trying to be a killjoy, but it is the correct answer nonetheless. Since there appears to be some confusion over why the answer is 'no', let me explain. First I'll define some terms, then the copyright status of journal abstracts, and finally why the policy of Wikipedia must be to exclude abstracts.

First the definitions. Don't quote me on these. Like I say, IANAL. These are all just definitions that I have picked up over the years in the context of Wikipedia and open-access. In order of increasing protection of rights:

  • Public domain: completely exempt from all rights given by copyright law. Anyone can reprint it, remix it, and make money selling it, with no obligations.
  • Public/copyleft licensed, e.g. GFDL, CC-BY: the producer of the work has asserted their ownership and claim their rights, but have voluntarily given everyone in the world permission to do certain things with the work without having to ask first. There are actually several tiers of these licenses.
  • Copyright: you're not allowed to do anything with the work, unless the copyright owner has said you can.
Public domain is not a synonym for "publicly available". Something is not "in the public domain" just because it is on the internet -- indeed, most of the internet is not public domain, it falls in that third category. There is no presumption that you are allowed copy and paste material all over the internets. Perhaps there are corners of the internet where that is de facto the case, and perhaps it would be great if everything was public domain or copyleft, but it's not. Napster was a place where music was de facto public domain, before the recording industry reminded them that the law doesn't work that way. However, there is a fourth area to copyright: fair use.

Fair use is not a fourth category, like the categories above. Fair use is just a set of exemptions to copyright protections. It allows you to make use of copyrighted material without the owner's permission to do so. However, it is very limited: you may only use a limited amount of the copyright material, and you can only do a limited range of things with it. If you want to use something copyrighted and say that you are doing so under fair use provisions, you have to make the case for your specific creation being fair use of the material. Getting away with claiming fair use for an abstract in PubMed does not mean that you will get away with it for Wikipedia, or some other creation. And the copyright owner is always within their rights to object to your fair use claim.

The copyright status of journal abstracts. Copyright to most journal abstracts will be owned by the journal's publisher (or society). Copyright to others will be owned by the authors. For open-access papers, the copyright is usually owned by the authors, but the journal has made sure that they have released it under a copyleft license, allowing you to do lots of things with their work. Papers written by employees of US federal agencies in the course of their employment will be public domain, as will very old papers.

It is true that there is a culture amongst scientists of free movement of published ideas. Copyright is worthless to a scientist, who actively wants his ideas to spread, so long as he is cited and acknowledged. Scientists freely share and reprint things like abstracts.

Scientists assume that publishers feel the same about all use of "their" material. Note the fierce and desperate opposition some of the traditional publishers raise against the open-access movement, though. Ideas mean different things to a scientist and to a (traditional) publisher. You shouldn't presume that publishers will react in the same laid-back way as scientists do when the words that "belong" to them are used in novel ways.

Note that PubMed carefully argues the case that its use of abstracts falls under fair use provisions. It doesn't just say "yeah, whatever, everyone freely reproduces abstracts, no one cares."

Why you can't turn abstracts into Wikipedia articles. Wikipedia can't be laid back about copyright any more than PubMed can. Wikipedia is now, what, a top-ten website by most metrics? People notice things that are put on Wikipedia. If you start putting abstracts on it, somewhere a publisher will notice, not like it, and have the material removed. You could claim fair use, but (and remember, IANAL), I very much doubt you would be successful: an encyclopedia is very different to an index, and in Wikipedia you are remixing the material. Well, whatever. One page gets deleted. No lasting harm done. End of story?

Not exactly. Wikipedia is GFDL. What you put on Wikipedia gets copied to hundreds of mirrors and put in paper versions. People use it for whatever commercial purposes they want, and it gets remixed to death. It's difficult to undo what goes into Wikipedia. That is why, when you write in Wikipedia, you must declare either that the words are your own, or that they are already released under a compatible copyleft license. You are not just giving permission for your words to be used on Wikipedia, you are giving permission for your words to be reused and remixed for virtually any purpose. This is why Wikipedia has to be pretty careful not to let copyright violations through.

This is also why Wikipedia does not actually allow any text to be contributed as fair use (except when marked as quotations): the permissions granted by Wikipedia are just too great for the fair use claim to be defensible.

But can't Wikipedia make an exception for abstracts? Theoretically, perhaps it could be done, but sadly, the reality is 'no'. Wikipedia is too big, too old, too well known, too bureaucratic. Wikipedia's policy on copyrights is well established; it must be generalist, covering all fields and all nations, and it can't afford to be lax. To come up with exceptions to the policy would be too difficult for such a generalist site with such a tiny legal team. The Wikipedians would have to establish beyond doubt that publishers were happy for their abstracts to be used not just on the encyclopedia, but by anyone, anywhere, for virtually any purpose, reprinted and remixed. And that sounds like the open-access movement to me.

Conclusions. You can't put (non-open access) abstracts on Wikipedia. It would be nice if the gentlemen's agreement whereby publishers overlooked reuse of their material by scientists extended to all spheres, but that ain't necessarily so. Of course, it would great if it were so, and the story is just one of thousands which emphasise the need for a more rational and restricted copyright system.

3 Mar 2010

Peter Suber's open access word contest

Peter Suber, the guru of open access, has challenged readers of the SPARC Open Access Newsletter to come up with a new word.

English speakers need a verb that means "to provide OA to". It should be as succinct as "sell" for use in sentences such as, "We sell the print edition but ____ the digital edition."
Oh, the joys of verbing a noun. Here are my entries:
  • "Openpublished"; "to openpublish" (or "open-published", "to open-publish"). Apparently there is already a meaning of "open publishing", which is to make the process of publishing transparent (open peer review would be an aspect of this, as well as Indymedia and Wikinews), but I think the term is little used.
  • "Commoned"; "to common". Meaning "to place into the commons", as most OA publishing uses the Creative Commons licenses.
  • "Publicked"; "to publick". Meaning "to make public". It's an archaic word, used by Joyce in Finnegan's Wake, sometimes meaning "published", sometimes meaning "populated", and recently resurfacing to mean making a private message public.
  • "Freeshared"; "to freeshare" (echoing freeware and shareware). This term is already a synonym for freecycling, and for a defunct image upload site.
  • "Openshared"; "to openshare" (echoing open source and shareware). This term is already used for an icon that represents the open sharing of content - an icon that could be adopted by the open access movement.
  • "Copylefted"; "to copyleft". Using the existing term, which refers to Creative Commons and GNU GPL licenses among others.
  • Referring to libre and gratis: "Libred"; "to libre". "Gratised"; "to gratis".
Can you do better? Seize the glory by emailing Peter.

The Open Share icon is under a Creative Commons Attribution-Share Alike 3.0 Unported License from http://www.openshareicons.com/.

27 Aug 2008

Defining Open Access: Gratis vs Libre

Peter Suber and Steven Harnad have introduced two new terms into the Open Access lexicon: gratis and libre.

I'll let Peter explain:

"When the Bethesda and Berlin statements came out (June and October 2003) they followed the Budapest statement in calling for the removal of both price and permission barriers. As a result, all three components of the Budapest-Bethesda-Berlin (BBB) definition of OA now call for both sorts of free online access.

But unfortunately we still don't have widely accepted terms for the two sorts of free online access: (1) the kind which removes price barriers alone and (2) the kind which removes price barriers and at least some permission barriers. This gap in our vocabulary has caused confusion and conflicts, not least because it created pressure to use the term "open access" for each. For now, my choice is to use "gratis" and "libre". They are accurate, neutral, and descriptive. In the neighboring domain of free and open source software, they exactly express the distinction I have in mind".
Gratis is cost free
It means free to read.

Libre is cost free & permission free

It means free to use.

Heather Morrison is a fan of these new terms, and I think they are going to catch on (although some are confused). I do still think that 'real' open access is more than just giving it away for free - permission barriers matter, and others like Jim Till agree. That the initial suggestions for gratis and libre were 'weak OA' and 'strong OA' speaks volumes.

A short post about Bentham Open

I've had my eye on Bentham Open since before various bloggers, Peter Suber and Richard Poynder raised concerns about their email marketing and the recruitment of their editorial boards.

When they launched they copied some of their instructions for authors verbatim from the BMC-series journals
, but the below really took the biscuit. Spot the difference. They stopped using that logo pretty sharpish; I think someone put a shot across their bows...




20 Aug 2008

My view of Scientific Journals International

Richard Poynder, Gunther Eysenbach and others have been investigating the practices of some of the new Open Access publishers, such as Bentham Open, Libertas Academica and Scientific Journals International (SJI). The fear is that an unscrupulous publisher might look on Open Access as a way to make a fast buck (in a "Gold Rush"), hoping to take advantage of the goodwill that many researchers have towards Open Access journals. There's a fine line between being a respectable Open Access publisher and a vanity publisher, and that line is held by rigorous peer review and good editorial processes. Quite rightly, a spotlight is being shone on the way that publishers are marketing themselves, recruiting editorial board members and conducting peer review. BioMed Central has faced similar scrutiny, and has weathered it.

Richard Poynder is a well-respected freelance journalist with an interest in the Open Access movement. He is known for his incisive interviews, and he has recently been asking whether anyone knows about SJI. His questions were prompted by researchers wondering about SJI:

"What kind of quality can I expect from a journal titled “Journal of Electronic Book”? Not to be too harsh, but it might be grouped with another journal such as “Journal of Gooder Grammar”."

"Nowhere on the website could I find any indication of who is actually behind these journals"

"SJI sometimes speaks of itself as a publisher of journals (plural) and sometimes of one multi-disciplinary journal (singular)."

"The fact that some of the lead authors of articles are using lycos and aol as email addresses really raises alarms"

In response, Zinath Rehana, co-founder of SJI, sent a lengthy post to the SPARC Open Access Forum, threatening to sue Richard Poynder and others for libel. This response is not very measured.
"Dr. Niaz [the founder of SJI] is also well aware of the realities of prejudice and racism, and knows how to deal with them with legal actions"

"Why is there such hostility toward an Asian American immigrant of 25 years?".
To bring the issue of race into this as Zinath Rehana has done is uncalled for. Dr Niaz's institution, St. Cloud State University, may have problems with racism but that does not mean that it is lurking around every corner. I see no reason to believe that Richard Poynder is motivated by racism. The further implication that Richard Poynder is in some way anti-Open Access is simply incorrect. I believe that Zinath Rehana was mistaken if she was hoping to garner support in the Open Access movement with her post to SOAF. Dorothea Salo isn't impressed, for starters. I think that it is best to answer legitimate concerns with openness rather than threats of legal action.

Zinath Rehana calls on other Open Access publishers for help against unfair criticism, but then goes on to criticise BioMed Central and PLoS for being unsustainable and profligate. The picture she paints of BioMed Central is not one I recognise - we're getting more submissions than ever, and rumour has it that we're 'in the black'.
SJI claims that article processing charges are not scalable, when that's exactly what they are. Zinath Rehana also neglects to mention the waiver schemes operated by PLoS and BioMed Central for authors who have difficulty paying. I don't think that criticising PLoS and BioMed Central is the best way to make friends in the Open Access movement.

While biomedical publishing is edging towards being open, SJI may be going the other way.
"We employ an innovative quadruple-blind review system, where the referees, authors and editors remain anonymous throughout the peer-review process. Names of the chief editor or associate editors are not published on SJI Web site. Authors or reviewers cannot contact the editors to influence the review process deliberately or unintentionally"
Quadruple blind? Does this mean that there is no editorial accountability? I believe that it is essential that people know who runs a journal, but authors and readers seem to have to take the editorial processes at SJI on trust.

The payment model of SJI is unusual. They charge article processing charges, but ask for more money the more authors there are. Articles do not cost more to process if they have more authors. This payment model might lead to authors being unfairly left off papers to save a group money. If authors do pay the fee it may be a canny move by SJI because the number of authors on scientific articles increases year by year.

There is an impressively long list of journals, but many are "Coming soon..." when you follow the links. How many active journals are there? There is an Editorial Board, but this spans across all the journals.
The journals have no scopes to my knowledge, no information on indexing, and I can find no information on the license under which the articles are published.

Importantly, there is no official information available on how peer review is conducted: who selects reviewers, who makes editorial decisions, how many reviewers are used, what are the editorial policies and standards? The only information we have about the peer review at SJI is from an anonymous comment on the Open Access blog. I hope that this is not an accurate or representative depiction. If it is, I would advise those running SJI to read and adopt the policies of the World Association of Medical Editors.

We need answers, not legal action.


This post is my opinion, and not that of BioMed Central

[Post edited 22/8/08 - I had not realised that Zinath Rehana is female]

3 Aug 2008

Bioinformation Journal: making sure "open access" means open access

When looking at the journal Bioinformation, I spotted the tagline

"It is free to publish, open access and online immediately upon acceptance"
This is wrong, as like the BioMed Central journals this journal usually charges an article processing charge. This got me digging a bit further.

They state on the published articles that
"This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original author and source are credited"
OK, although a non-commercial license isn't great, as Peter Murray-Rust has explained. Yet when I tried to right click on the page, a notice popped up:
"Sorry! Copying of these contents for potential editing and reproduction is not permitted. However, you have access to read, know and print contents for non-commercial processes".
This is not consistent with open access; it is a restriction of reuse. It also prevents 'fair use'.

The journal states that
"The authors of published articles in Bioinformation automatically transfer the copyright to the publisher upon formal acceptance. However, the authors reserve right to use the information contained in the article for non commercial purposes"
It is usual among open access journals that the authors retain copyright, and a Creative Commons Attribution license is applied. As the Budapest Statement on Open Access put it "The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited".

I emailed the editors and received a brief reply from Prof Kangueane. Now, a couple of weeks later, the tagline reads
"It is open access and online immediately upon acceptance"
Excellent. The right-click restriction also appears to be gone. I will leave it up to their authors and editors to lobby them to change from a CC-BY-NC to a CC-BY license, but it seems that Biomedical Informatics Publishing Group and Bioinformation are now doing things right.

29 Oct 2007

Conflicts of interest in the open access debate

I can accept that some society publishers are concerned that open access may make it harder for them to fund their activities. I can accept that some people are confused about the implications of open access.

What I find very difficult to accept is that executives at the American Chemical Society appear to be raising spurious arguments against open access, such as calling it 'Socialized Science', and that they have clear, undeclared conflicts of interest in this debate, namely that they are paid bonuses depending on the profits of the publishing division of the ACS.

Just as we now expect medics to declare their competing interests in journal publications, anyone involved in the open access debate should declare their own competing interests. My own financial competing interest is a fixed salary received from BioMed Central. Let's see some more transparency from all concerned.

Don't reinvent the wheel - jump on the bandwagon!

In A modest (billion-dollar) proposal, Alexandre Linhares suggests that "papers published online should be freely accessible to all, no login, no paywall, nothing in the way. Copyright should remain in the hands of authors".

I was surprised to read this, as I thought this was what we were doing already with the open access movement. I posted this in reply:

I completely agree. Stevan Harnad proposed something quite similar in his "Subversive Proposal" way back in 1994; he calls electronic publishing that is free of the tyranny of paper the "Post-Gutenberg World".

The Internet truly has allowed the beginnings of a revolution in scientific publishing. Vitek Tracz (my employer) launched BioMed Central in 1999, and Mike Eisen and Harold Varmus launched the Public Library of Science in 2000 (originally an advocacy organisation, now a publisher). BioMed Central and PLoS are the two biggest players in open access publishing. All our peer-reviewed research is immediately available online at no charge and with no access barriers. Copyright is retained by the authors. Under the Creative Commons license, anyone can copy and reproduce the articles: all anyone needs to do is properly attribute the source.

Some people thought that Vitek had lost it when he launched BioMed Central. Well, BioMed Central has seen our submissions double every 14-18 months, and PLoS has seen a similar rapid growth. Smaller open access publishers like JMIR, Hindawi, Libertas Academica are thriving. The impact on the world of publishing is clear – over the last two or three years, virtually every large biomedical publisher has begun to offer authors an option of publishing open access, and in physics CERN has even promised not to publish with any journal not offering an open access option.

The difference to your proposal is that we're not reliant on internet advertising, although we do make some income in this way. Being reliant on advertising risks making a journal answerable to its advertisers, as if they see something they don't like they can pull the plug - a similar state of affairs to that you claim that IBM Systems Journal is in. Because we don't charge readers, we've turned the funding model on its head. As publishing is in effect the final part of the research process, it makes sense to ask authors to fund the publication process, and we do this by charging authors (or more usually their institution or grant funding body) an article processing charge. This funding model scales perfectly with the amount of research conducted. PLoS has been quite reliant on philanthropic grants, but they are weaning themselves off these grants now that their high-volume journal PLoS ONE has been launched. There are several others way to fund open access journals, including society support; Peter Suber's blog is the best source of information on this.

The suggestion of only allowing searching on the journal website would leave a journal stillborn. The key to success is to have as many readers find and read the work as is possible – this is the whole point of open access! We are indexed and tracked by as many services as we can find, and we are mirrored by PubMed Central and on several other international websites. Authors want visibility, and that is what we give them.

Google have already made their first move into scientific publishing with Google Scholar, which is to my mind one of the most powerful ways to find scientific research. The full text of all of our articles is fully searchable by Google Scholar. Google's area of expertise is the organisation of information, and Google Scholar fits perfectly into this program. Microsoft is also moving in this direction – they have built their own literature search engine (Windows Live Academic Search), and Microsoft Research are sponsoring BioMed Central's latest research awards.

BioMed Central has its own publishing platform – we built it in-house, and we handle our own submissions, peer review and web publishing. We like to think that it is user friendly, we've certainly received positive feedback. We have an independent journals program that allows researchers and societies to launch new journals using our platform, or to transfer across existing journals. PLoS have their own platform and are working on an open source platform called Topaz, and an open source platform called Open Journal Systems is already being used by several small open access journals.

Our published articles already easily integrate figures and movies. Annotation of manuscripts and integration of figures and movies during peer review would be a boon, and several publishers included BioMed Central are looking into this, but it is hardly a 'killer app'. We can already handle LaTex (familiar to many mathematicians and computer scientists) and Wolfram’s Publicon, both easy for typesetting, and we have little trouble with MS Word or PDFs.

Google or Adobe don't need to reinvent the wheel, but they could certainly jump onto the open access bandwagon. It's already rolling at quite a pace.

Conversion to open access

Stevan Harnad is arguing again that conversion of journals to open access is a distraction to self-archiving, which he believes will more quickly and broadly deliver open access.

He suggests that publishers face a 'Prisoner's Dilemma' in converting from toll access to open access. The prisoner's dilemma is when two prisoners are being interrogated. If both stay quiet and refuse to implicate each other, they may get a short sentence. This is an example of 'honour among thieves'. If one implicates the other, they will get let free and the other will be punished. But if each implicates the other, both get severely punished. While I can see how Game Theory in general is worth invoking in this debate, I cannot see how the Prisoner's Dilemma translates to journal publishing strategies. Maybe I'm just being slow.

I don't believe that open choice options bring the major conflicts that Stevan describes. While I much prefer full open access journals, a transition to open access via open choice means that journals maintain a stable source of income. The alternative of shifting to open access only by mandating self-archiving creates an unstable situation in which journals may face widespread cancellations from libraries, without having set in place the alternative models needed once you cannot charge your readers (article processing charges, advertising, volunteerism or grants). Peter Suber, as ever, has written on this extensively, so I won't repeat all of this in depth.

Among publishers who are converting to open access, Oxford Journals deserve being singled out for praise. Not only do they already have several fully open access journals, but their Oxford Open scheme is transparent and well advertised. What is more, they are actively adjusting the subscription charges on their online journals based on the income they are receiving from the Oxford Open option. They are an excellent example of the way that publishers can adjust to the open access revolution.

2 Sept 2007

PRISM are scum

The Partnership for Research Integrity in Science & Medicine (PRISM) are scum.

Their arguments against open access are stupid, tired and old, and have been dealt with before.

Rather than dealing with this tripe all over again, instead here are some links to the explosion of reaction on the blogosphere.

The Partnership for Integrity in Science Dissemination (PISD) are also in on the act, arguing that if open access were to come to fruition "civilization would suddenly collapse. Cities would rust, industries would implode, dinosaurs would once again rule the Earth".
A Blog Around the Clock has the definitive run-down on the reactions.
Of course, Peter Suber!
Bryan Vickery has posted BioMed Central's response.
The Scientific Activist: Now that is one ugly PRISM.
Peter Murray-Rust: Analysis and letters to OUP and CUP.
Bill Hooker has a lot to say.
Jonathan Eisen calls for a boycott of the AAP.
open... Through a PRISM darkly.
The Daily Transcript.
Boing Boing points out PRISM's copyright infringement.
putting down a marker.
Caveat Lector pulls no punches!
Confessions of a Science Librarian: "a sad, pathetic story".
Living the Scientific Life.
Bayblab.
Open Access Stole Christmas.
Adventures in Science and Ethics.
Heather Morrison.
Women's Bioethics Project.
Wired: Astroturf spreads to science journals.
PRISM bullshit and hypocrisy.
Stevan Harnad.

And finally... separated at birth?















Eric Dezenhall, anti-OA lobbier.



Dr
Evil.

Comparison and images taken from the post Evil is his one and only name on Science After Sunclipse.

10 Jul 2007

Open Choice takes a beating

I've been impressed with the way that publishers have begun the shift to open access with schemes such as Springer's Open Choice, offering authors the choice to have their article made open access in an otherwise subscription journal, depending on the payment of a fee ($3000 for Springer).

Stevan Harnad has criticised Open Choice, arguing against double payment (readers and authors in effect paying for the same article), and what Stevan sees as the way that paying for open access publication is a distraction from self-archiving.

Now, Open Choice is being criticised from another front: researchers such as Peter Murray-Rust who are keen on open access publication, but who find that Open Choice does not quite meet the usual standards they expect of open access.

Peter Murray-Rust has resigned from the editorial board of a Springer journal in protest at the way that Open Choice is working. In particular, he is concerned at the lack of visibility or explanation of Open Choice, other than just a small logo
as well as the way that Springer retains copyright to the articles (Open Choice articles seem to be © Springer, although information on the Springer site states that "if authors choose open access in the Springer Open Choice program, they will not be required to transfer their copyright to Springer"). One of his real concerns is about the transparency of permissions to reuse the work, a criticism that has also recently been raised about self-archiving with the battle cry, 'Free is not open!' (it is unusual to see Stevan and Jan Velterop, Springer's open access champion on the same side of an argument). Jan has responded to Peter, to which Peter has replied, clarifying his worries.

One thing that Peter noted really did surprise me. Although readers can access Open Choice articles without charge, on the page there is a link that invites readers to 'Add to shopping cart'. There is also a 'Request Permissions' link, which if you follow tells you that "To request reuse of content from this Springer Science+Business Media journal, please e-mail Springer Rights & Permissions directly at permissions.heidelberg@springer.com for assistance". No mention of Open Choice.


Click the link to 'Add to shopping cart', and you are told that you can purchase it (for $32 in this case). I thought that it was unlikely that a reader would really be able to proceed with the purchase of an article that is actually open access, but I got all the way to being asked for my credit card details with no warning that I was about to pay for something that was free! This problem of people paying for articles that they could access for free elsewhere is an issue with self-archiving, but it really shouldn't be possible when the publisher has already been paid by the author!



As if criticisms of double payment weren't bad enough, this appears to be triple payment (subscribers to the journal, authors, and readers of the individual article who purchase it without realising it is open access). I wonder how many readers have made this mistake, if any? I take no delight in highlighting this criticism of Springer, as the blind spots in their implementation of open access are surprising considering Jan Velterop's genuine dedication to the cause of open access (his blog is called The Parachute, because 'it only works when it is open'). I'm sure that Jan will be working to fix these glitches in Open Choice.

10 May 2007

Journalology roundup #7

Scooped by a blog. A then PhD student Reed Cartwright came up with the same hypothesis on his blog as an accepted paper in Plant Cell, so the author offered him co-authorship on the paper. A nice feel-good story, but by Reed's admission "There are maybe three sentences in the published paper that I had anything to do with". I might be a spoil-sport, but I think that an acknowledgement would have made more sense! Reed's blog is here.

Physician-Industry Relationships. "Most physicians (94%) reported some type of relationship with the pharmaceutical industry, and most of these relationships involved receiving food in the workplace (83%) or receiving drug samples (78%). More than one third of the respondents (35%) received reimbursement for costs associated with professional meetings or continuing medical education, and more than one quarter (28%) received payments for consulting, giving lectures, or enrolling patients in trials".

The Scientist's take on the Shelley Batts figure reuse affair.

Characteristics Associated with Citation Rate of the Medical Literature. "Large trials, with group authorship, industry-funded, with industry-favoring results, in oncology or cardiology were associated with greater subsequent citations". This is the kind of journalology research I love to see!

Open Access & Science Publishing. Results of a Study on Researchers’ Acceptance and Use of Open Access Publishing

In the eye of the Open Access storm. "Publisher Matthew Cockerill is one of the father figures of open access. So, exactly how open is he?". A profile of our Dear Leader.

6 May 2007

Obscurity is a far greater threat to authors than piracy

Five years ago, Tim O'Reilly of Web 2.0 fame noted down several thoughts about online information distribution. Although his comments are focussed on music, film and book publishing, many of them equally apply to journal publishing.

My particular favourites are "Obscurity is a far greater threat to authors and creative artists than piracy", which captures the imperative of the open access movement, and "File sharing networks don't threaten book, music, or film publishing. They threaten existing publishers". This could have been written about self-archiving.

20 Apr 2007

Archivangelism - has the means become the end?

Stevan Harnad has always been insistent on the need for immediate, free access to academic research, and he sees self-archiving as the means to this end.

Now that he recognises that self-archiving may only be compatible with some publishers if there is a delay in access, Stevan (who is normally uncompromising, e.g. "OA itself is non-negotiable") seems to have accepted this fudge, which is not immediate free access: "Access to the immediate deposit can then either be set as Open Access immediately, or (in case of a publisher embargo), as Closed Access, provisionally". This is the "Immediate-Deposit & Optional-Access" (IDOS) policy. Even with a fancy name, and as Jan Velterop has noted, it's not open access.

Stevan has been adamantly against the crystal-ball-gazing that predicts a loss in subscriptions resulting from self-archiving, but his own crystal ball predicts that following a universal adoption of 'IDOS' repositories, "Embargoes will disappear very soon thereafter" [my emphasis].

Stevan has criticised advocates of open access journals who claim that open access journals will reduce costs, as he insists that it is access that is paramount and not costs, which is a fair point. Yet he now criticises open access journals and hybrid journals for the extra costs he says they impose, for example criticising CERN's decision to put up funds to pay for article processing charges as "diverting scarce research funds from research to paying publishers". It seems that if open access journals might save costs, that's a side issue; if they might cost more, we should take heed.

While there might be issues with double-payment in hybrid journals, that can be corrected by adjusting subscription costs - it isn't an insurmountable issue. Further, open access journals don't have this problem, but Stevan's criticisms of Springer Open Choice don't often allow for this distinction. How open access can be paid for is open to debate - the debate has usually focussed on the article processing charge, but as Peter Suber has noted not all open access journals charge author fees. Costs can also be met using advertising (though hardly an uncontroversial way for a medical journal to recover costs), grants from societies (this is how the Beilstein Journal of Organic Chemistry is funded), charitable and philanthropic donations, or even by cutting costs. An interesting aspect of article processing charges is that they can result in price competition on an article-by-article basis.

Rather than being a system with no barriers to access (the definition of open access as I understand it), under self-archiving each author (having signed over copyright to the publisher) needs to deposit their articles in their local repository (if one exists), then each reader needs to realise that the repository exists, find the article, and then possibly have to contact the author to get a copy, and then have the author respond and send it to them. Sadly, this seems to be laborious, incomplete and prone to failure. I had thought that the launch of Google Scholar opened up the possibility of self-archiving really being viable, but their practice of linking to all copies of an article that could be found on the web only lasted a few short months and links to free versions are now intermittent - possibly (probably), Google were sat on by publishers.

Libraries will apparently continue to subscribe to journals that their users can access at no cost, despite evidence that libraries are acutely attuned to cost, and an existing trend of university actions against high journal prices. Publishers will apparently be happy to have a business model that depends on their customers paying for a product that can be obtained for free. This business model is actually seen in shareware, though shareware is much rarer now than 10 to 20 years ago, and certainly the music industry isn't too keen on this business model. If self-archiving doesn't cause a collapse in subscriptions to closed access journals, I'd suggest that it will implicitly have failed to achieve its goal. Surely the aim is to provide immediate free access to peer reviewed academic research - if libraries and readers are unaware that they could get what they are still paying for at no cost, might that not imply that self-archiving doesn't provide universal access? Might there be those who aren't paying and who don't realise that the research is accessible, and therefore never read the article? We need to end this farcical situation of researchers not reading articles, and although I like the idea of self-archiving I don't believe that if offers a complete enough solution, or is sustainable.

Stevan's insistence on self-archiving has even extended to criticising central deposit in PubMed Central, arguing that articles must only be deposited in institutional repositories. What is BioMed Central to do; stop depositing in PubMed Central? It's hardly as though we block our authors depositing in their own local repositories.


Stevan lays claim to being the true voice of open access. In responding to an article by Ben Goldacre he argued that "It is not "two [Gold] OA publishing organisations" that have led the fight for OA, but one (Green and Gold) organisation -- the same one that first coined the term OA in 2002: the
Budapest Open Access Initiative (BOAI)". Actually, it's not true that BOAI coined 'open access'.

Stevan at times appears to be entirely opposed to the idea of open access journals (despite apparently supporting the idea a decade ago), for example raising criticisms against BioMed Central as a publisher from the outset.

I can't agree with Stevan's insistence upon local institutional self-archiving to the apparent exclusion of other approaches to open access.
It appears to me that with archivangelism the means has become the end.

19 Mar 2007

Who pays the fiddler calls the tune?

"In our capitalist society, one of our basic tenets is who pays the fiddler calls the tune". This was a comment by Jeffrey Drazen, Editor-in-Chief of the New England Medical Journal, referring to the idea that because many open access journals charge an article processing charge rather than a subscription fee (including most of BioMed Central's), they will lower their standards to take the cash.

Peter Suber has already countered that slur criticism in detail, so I don't need to repeat the arguments here, but I think that it's worth noting that in my time at BioMed Central I've seen the acceptance rate fall by at least 10% on the BMC series. This is not exactly what you'd expect from a vanity publisher pushing its editors hard to accept articles no matter the quality, in order to take the cash. In case I've been too subtle, that's because BioMed Central is not a vanity publisher, and payment and publisher finances are kept separate from editorial decision making. Matt Cockerill doesn't stand over us with a whip, demanding more acceptances.

The reason I quoted Jeffrey Drazen above is that I think that there's quite an irony here. The NEJM raised $30 million in advertising revenues in 2005, with nearly 5000 pages of advertising. Is Dr Drazen admitting that one of the "basic tenets" of the NEJM is that the advertisers call the shots? [Shome mishtake, shurely?]

10 Mar 2007

Tags track growth in open access (and a dig at Philica)

An interesting observation: Tags Indicate That Open Access Is Flourishing. Comparing the growth in Connotea tags for "Internet" to the growth in tags for "Open access", the growth in tags for "Open access" is significantly higher.

On the topic of tags, Matt Cockerill on the BMC Blog discusses the tags used to tag BioMed Central articles on CiteULike. BioMed Central is working with CiteULike and is keen to capture the power of "Web 2.0".

So, Philica. The above observation by James Till on Philica seems much more suitable for a blog than an academic journal. Philica has yet to prove itself to be a serious academic journal -
much of the content seems to be trivial or pseudoscience, e.g. this, or this, or this.

Philica brings the much touted idea of community peer review to fruition, leaving peer review entirely to the readers. It has what I believe to be two fatal flaws. Firstly, it has absolutely no editorial selectivity and the requirement that authors be based at an academic institution has proven to be no barrier to junk being submitted. Not many researchers have the time to spend critiquing palpable nonsense. Secondly, it has no mechanism to solicit reviews from experts - only those who stumble across Philica will read the articles, and they probably won't feel at all obliged or inclined to review. Peer review survives because editors deliberately select those they believe are best placed to comment, and sometimes hound them for a review - remove a selection process, and it would collapse.

I'm not the only one to be skeptical about Philica. It's a great idea (I sketched out a similar idea last year and bored my colleagues with it at the pub), but it's not working.